Griffith O W, Bridges R J, Meister A
Proc Natl Acad Sci U S A. 1981 May;78(5):2777-81. doi: 10.1073/pnas.78.5.2777.
These studies indicate that gamma-glutamylcyst(e)ine, found in the urine of a patient with gamma-glutamyl transpeptidase deficiency and also in the urine of experimental animals injected with glutathione or with inhibitors of gamma-glutamyl transpeptidase, is formed by the action of gamma-glutamyltranspeptidase. The evidence demonstrates that transpeptidation between glutathione and cystine occurs in vivo and also that this reaction constitutes a significant physiological function of the enzyme. The appearance of large amounts of gamma-glutamylcyst(e)ine in the urine seems to reflect an inhibitory effect of glutathione on the transport of gamma-glutamylcyst(e)ine into cells. The findings also indicate that conversion of glutathione to gamma-glutamylcysteine by hydrolytic cleavage of the COOH-terminal glycine moiety of glutathione (or analogous cleavage of glutathione disulfide) is not a quantitatively significant pathway. The results reported here show that gamma-glutamyl transpeptidase activity is not completely absent in a patient found to have a deficiency of this enzyme and that the activity of the enzyme is not abolished in experimental animals treated with potent gamma-glutamyl transpeptidase inhibitors.
这些研究表明,γ-谷氨酰半胱氨酸存在于γ-谷氨酰转肽酶缺乏患者的尿液中,也存在于注射了谷胱甘肽或γ-谷氨酰转肽酶抑制剂的实验动物的尿液中,它是由γ-谷氨酰转肽酶的作用形成的。证据表明,谷胱甘肽和胱氨酸之间的转肽作用在体内发生,并且该反应构成了该酶的一项重要生理功能。尿液中大量γ-谷氨酰半胱氨酸的出现似乎反映了谷胱甘肽对γ-谷氨酰半胱氨酸进入细胞的转运具有抑制作用。这些发现还表明,通过水解谷胱甘肽的COOH末端甘氨酸部分(或谷胱甘肽二硫化物的类似裂解)将谷胱甘肽转化为γ-谷氨酰半胱氨酸并非一条数量上显著的途径。此处报道的结果表明,在被发现患有该酶缺乏症的患者中,γ-谷氨酰转肽酶活性并未完全缺失,并且在用强效γ-谷氨酰转肽酶抑制剂治疗的实验动物中,该酶的活性也未被消除。